XOMA Royalty Corporation (NASDAQ: XOMA) (“XOMA Royalty” or the “Company”), a biotechnology royalty aggregator playing a distinctive role in helping biotech companies achieve their goal of improving human health, announces the Company has successfully completed its previously announced tender offer to acquire all outstanding shares of Turnstone Biologics Corp. (NASDAQ: TSBX) common stock for a price per share of $0.34 in cash (the “Cash Amount”), plus one non-tradeable contingent value right (“CVR” and together with the Cash Amount, the “Offer Price”). Following the closing of the tender offer, XOMA Royalty merged Turnstone with and into a subsidiary, XRA 3 Corp. (the “Merger”). As a result of the Merger, Turnstone became a wholly owned subsidiary of XOMA Royalty.
Read the full article: XOMA Royalty Announces Closing of Tender Offer for Turnstone Biologics //
Source: https://www.globenewswire.com/news-release/2025/08/11/3130961/7281/en/XOMA-Royalty-Announces-Closing-of-Tender-Offer-for-Turnstone-Biologics.html
